Routine

Painful peripheral neuropathy — diabetic & other polyneuropathy (distal symmetrical sensorimotor neuropathy)

Peripheral nerve disorder · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic length-dependent (glove-and-stocking) sensory/sensorimotor neuropathy, commonest cause diabetes; also alcohol, B12 deficiency, hypothyroidism, CKD, drugs (chemo), paraproteinaemia, vasculitis, hereditary. Focus: identify & treat reversible causes, control neuropathic pain, protect insensate feet. (Acute ascending = GBS; relapsing = CIDP — different.)

Red flags

  • Asymmetric, stepwise, or mononeuritis multiplex pattern — vasculitic neuropathy (urgent — needs immunosuppression)
  • Rapidly progressive or proximal + distal weakness, areflexia — GBS (acute) or CIDP (chronic/relapsing, treatable)
  • Predominant motor involvement, demyelinating NCS — CIDP
  • Autonomic failure, weight loss, systemic symptoms — paraneoplastic/amyloid
  • Foot ulcer, cellulitis, deformity (Charcot) — limb-threatening, urgent foot team

Assessment

Differential diagnosis

  • Diabetic / prediabetic neuropathy (most common)
  • B12 / folate deficiency (SACD)
  • Alcohol-related, nutritional
  • Hypothyroidism, chronic kidney disease, liver disease
  • Drug/toxin (chemotherapy — vincristine/platinum/taxanes, isoniazid, amiodarone, metronidazole, lead)
  • Paraproteinaemia / monoclonal gammopathy, amyloid
  • Vasculitic neuropathy (mononeuritis multiplex)
  • CIDP (if proximal + distal, motor, relapsing/progressive — treatable)
  • Hereditary (CMT), HIV, leprosy (consider in endemic areas/India)

Investigations

  • Bloods: HbA1c/fasting glucose (+OGTT if normal but suspicious), FBC, U&E, LFT, TFT, B12 & folate, ESR/CRP
  • Further if cause unclear: serum protein electrophoresis + free light chains/immunofixation, ANA/ANCA, HIV, coeliac serology
  • India/endemic: consider leprosy (thickened nerves, skin patches) and screen as indicated
  • Nerve conduction studies/EMG if diagnosis unclear, asymmetric, predominantly motor, or rapidly progressive (distinguish axonal vs demyelinating — CIDP)
  • Examine feet: monofilament, vibration, ankle reflexes, foot deformity, ulcers; assess for autonomic features
  • Genetic testing / nerve biopsy only in selected specialist cases

Management

  • Confirm length-dependent symmetrical pattern; screen for and treat reversible causes (glucose control, B12 replacement, thyroid, alcohol cessation, remove offending drug)
  • Optimise glycaemic control in diabetes (slows progression; note rapid tightening can cause treatment-induced neuropathy)
  • Daily foot care & protection: inspect feet, well-fitting footwear, podiatry referral, treat ulcers early — prevent diabetic foot complications
  • Treat neuropathic pain: start one first-line agent, titrate to effect, switch class if ineffective at adequate dose/duration (~12 weeks)
  • Avoid opioids/tramadol for chronic neuropathic pain (AAN) — poor efficacy, dependence
  • Address sleep, mood, function; topical agents for localised pain
  • Refer neurology if atypical (asymmetric, motor-predominant, rapid, demyelinating features — ?CIDP/vasculitis)
  • Screen for and manage autonomic neuropathy (postural hypotension, gastroparesis)

Drugs & doses

First-line neuropathic pain (NICE CG173 — choose one, titrate, switch if needed): amitriptyline 10-25 mg PO nocte, titrate to 75 mg (max per tolerance) [verify local dose]
OR duloxetine 30 mg PO OD, increase to 60 mg OD (first-line in diabetic neuropathy)
OR gabapentin 300 mg PO OD, titrate by 300 mg every few days to 900-3600 mg/day in 3 divided doses
OR pregabalin 75 mg PO BD, titrate to 150-300 mg BD (max 600 mg/day)
Sodium-channel blockers now also recommended (AAN 2022) e.g. carbamazepine/oxcarbazepine [verify local]
Localised pain: capsaicin 8% patch or lidocaine 5% plaster (specialist)
Treat cause: hydroxocobalamin IM for B12 deficiency; thiamine/B-complex for alcohol-related; optimise glycaemia
Avoid opioids, tramadol, tapentadol for chronic diabetic neuropathy (AAN)

Disposition

Outpatient: start pain control, treat reversible causes, podiatry + GP follow-up. Neurology referral if atypical/CIDP/vasculitis suspected. Urgent referral/admission for acute foot infection, limb-threatening ulcer, or rapidly progressive weakness.

Complications & pitfalls

  • Diabetic foot ulceration, infection, Charcot arthropathy, amputation
  • Falls from sensory ataxia
  • Chronic pain, sleep disturbance, depression
  • Autonomic complications (postural hypotension, gastroparesis, erectile dysfunction)
  • Missed treatable cause (CIDP, vasculitis, B12 deficiency)

Exam pearls

  • Always screen for reversible causes — B12, thyroid, glucose, alcohol, drugs — before labelling 'idiopathic'
  • AAN 2022: TCAs, SNRIs, gabapentinoids and sodium-channel blockers are all effective for painful diabetic neuropathy; opioids/tramadol are NOT recommended
  • Asymmetric or motor-predominant neuropathy is a red flag — think CIDP or vasculitis (treatable) and refer
  • Foot protection and podiatry prevent amputation — the single most important intervention in diabetic neuropathy
  • In India/endemic regions, consider leprosy (thickened nerves, hypopigmented anaesthetic patches)

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.